We are live on ! Find out more
DP

Dearborn Partners Portfolio holdings

AUM $1.85B
1-Year Est. Return 6.59%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+6.59%
3 Year Est. Return
+44.33%
5 Year Est. Return
+68.05%
10 Year Est. Return
+241.41%
AUM
$2.39B
AUM Growth
-$77M
Cap. Flow
-$31.6M
Cap. Flow %
-1.33%
Top 10 Hldgs %
27.24%
Holding
278
New
12
Increased
90
Reduced
122
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 25.72%
2 Industrials 14.79%
3 Financials 10.99%
4 Healthcare 10.98%
5 Consumer Discretionary 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
276
State Street Energy Select Sector SPDR ETF
XLE
$39.2B
-5,196
Closed -$228K
IBDP
277
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
-21,357
Closed -$538K

Similar funds

Dearborn Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Dearborn Partners held 278 positions worth $2.39B, down 3.1% from $2.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dearborn Partners's Q4 2024 filing shows 12 new, 90 increased, 122 reduced and 19 closed positions. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 22,655 shares worth $517K. The largest sale was Elevance Health, an estimated $29.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Financials.

  • Dearborn Partners's largest Q4 2024 buy was iShares iBonds Dec 2029 Term Corporate ETF: 22,655 shares worth $517K.
  • Dearborn Partners added most to Corteva in Q4 2024, an estimated $31.8M increase.
  • Dearborn Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $20.6M.
  • Dearborn Partners fully exited Elevance Health in Q4 2024, selling an estimated $29.9M.
  • Dearborn Partners's ten largest holdings make up 27% of its $2.39B portfolio in Q4 2024.
  • Dearborn Partners opened 12 new positions and closed 19 in Q4 2024.
  • Dearborn Partners's portfolio value fell 3.1% quarter-over-quarter to $2.39B.

Based on Dearborn Partners's 13F filing for Q4 2024, filed 7 Feb 2025.